First-in-class, first-in-human phase I trial of KPT-330, a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Razak, Albiruni RA
  • Soerensen, Morten Mau
  • Mahipal, Amit
  • Shacham, Sharon
  • Yau, Cindy YF
  • Lassen, Ulrik Niels
  • McCauley, Dilara
  • Cooksey, Jennifer
  • Tan, David Shao Peng
  • Saint-Martin, Jean-Richard
  • Landesman, Yossi
  • Pond, Gregory
  • Oza, Amit M
  • Kauffman, Michael
  • Siu, Lillian L
  • Mirza, Mansoor Raza

publication date

  • May 20, 2013